Embrace Free Market Solutions Over Harmful H.R. 3 Legislation
April 21, 2021 CASE Statement: As a leading advocate for consumers and patients across the country, Consumer Action for a...
CASE Op-Ed – Morning Consult: COVID-19 Provides a Roadmap for Effective Health Care Policy
Matthew Kandrach – President, CASE April 16, 2012 In a milestone revelation this month, it was announced that the United...
The Consequences of Price Controls for Patients
2021 could be a bad year for patients in the United States. Lawmakers have resumed their fight to pass sweeping price...
More Socialized Medicine: CASE Opposes Dangerous Anti-Consumer Healthcare Proposal
June 29, 2020 As an advocate for consumers across the country, CASE urges House lawmakers to vote against H.R. 1425,...
CASE Joins Coalition of 75 Free-Market Groups Opposed to “Medicare for All” Styled Price-Fixing Schemes
December 5, 2019 Click Here to see full coalition letter. Text of Letter: We represent fiscal conservatives and free...
Don’t Smoke ‘Em if You Got ‘Em – Pelosi Drug Pricing Bill is Like Two Pack-a-Day Habit
December 4, 2019 A new report issued this week by the President’s Council of Economic Advisers (CEA) provides a startling snapshot of...
CASE Op-Ed – InsideSources: Government Mandates Are Wrong Solution to Surprise Medical Bills
Gerard Scimeca – Chairman, CASE October 8, 2019 There is an impulse among some lawmakers that whatever the problem, more...
Why Congress Shouldn’t Meddle with the Market Forces in Medicare Part D
July 8, 2019 43 million seniors in the United States rely on Medicare Part D to provide them with the...
The Problem With Price Caps: Why CMS Should Rethink Its Part B Proposal
This week, we submitted comments to Health and Human Services (HHS) Secretary Alex Azar, urging him to reevaluate and abandon...
- 1
- 2
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/